Studies have found that B3GNT6 is closely related to a variety of disease processes, such as immunity deficiency,21 colorectal cancer and m6A modification,22 Together, these results indicate that B3GNT6 may be the downstream target of IGF2BP2. Here, IGF2BP2 is linked to colorectal cancer.